PWA
GMAB icon

Principia Wealth Advisory’s Genmab GMAB Stock Holding History

Principia Wealth Advisory’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37K Buy
50
+18
+56% +$478 ﹤0.01% 695
2026
Q1 		$859 Sell
32
-1
-3% -$30 ﹤0.01% 740
2025
Q4 		$1.02K Sell
33
-1
-3% -$31 ﹤0.01% 663
2025
Q3 		$1.04K Buy
34
+21
+162% +$512 ﹤0.01% 629
2025
Q2 		$269 Buy
+13
New +$267 ﹤0.01% 862

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Principia Wealth Advisory's GMAB Position: Q2 2026 in Review

Principia Wealth Advisory increased its Genmab (GMAB) stake by 56% in Q2 2026, buying an estimated $478 and bringing the position to 50 shares worth $1.37K. The position accounts for ﹤0.01% of the portfolio, ranked #695.

Principia Wealth Advisory first reported a position in GMAB in Q2 2025 and has held it in 5 quarters since. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Principia Wealth Advisory held 50 shares of Genmab worth $1.37K as of Q2 2026.
  • Principia Wealth Advisory bought 18 Genmab shares in Q2 2026, an estimated $478.
  • Genmab made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q2 2026, its #695 holding.
  • Principia Wealth Advisory first reported a position in Genmab in Q2 2025 and has held it in 5 quarters since.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.